Anacor Pharma (ANAC) reports partner GlaxoSmithKline (GSK) has voluntarily paused enrollment of ongoing GSK '052 Phase 1, 2 Clinical Trials
Go back to Anacor Pharma (ANAC) reports partner GlaxoSmithKline (GSK) has voluntarily paused enrollment of ongoing GSK '052 Phase 1, 2 Clinical Trials| ANACOR PHARM (NYSE: ANAC) | Delayed: 10.19 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.19 | 52 Week High | $156.93 | |||
| Open | $0.21 | 52 Week Low | $52.00 | |||
| Day High | $10.19 | P/E | N/A | |||
| Day Low | $10.19 | EPS | $-1.54 | |||
| Volume | 31,520 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 48.13 +0.01 (0.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $48.12 | 52 Week High | $45.58 | |||
| Open | $48.70 | 52 Week Low | $37.82 | |||
| Day High | $48.80 | P/E | N/A | |||
| Day Low | $47.85 | EPS | $0.00 | |||
| Volume | 2,281,892 | |||||
